The CypA inhibitor Debio-025 (Alisporivir) is a non-immunosuppressive analog of CsA and exhibits potent antitumor and antimetastatic activity by inhibiting the Crk signaling pathway in breast cancer [96]. Here, PPIA is linked to breast carcinoma.